An investigation of the stability of emerging new psychoactive substances

Drug Testing and Analysis

Volumn 6, Issue 7-8, 2014, Pages 696-704

  Soh, Yan Ni Annie ^a   Elliott, Simon ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b Inverness Medical Innovations   (United States)

Author keywords

Blood; Designer drugs; New psychoactive substances; Plasma; Stability

Indexed keywords

BIOMOLECULES; BLOOD; DEGRADATION; DIGITAL STORAGE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIGH PRESSURE LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PLASMA STABILITY;

ANALYTICAL CHALLENGE; ANALYTICAL STRATEGY; BLOOD; BREAKDOWN PRODUCTS; DEGRADATION PRODUCTS; DESIGNER DRUGS; DETECTION AND IDENTIFICATIONS; DRUG OF ABUSE; IN-VIVO; NEW PSYCHOACTIVE SUBSTANCE;

METABOLITES;

1 (BENZOFURAN 5 YL) N METHYLPROPAN 2 AMINE; 2 (4 CHLORO 2,5 DIMETHOXYPHENYL) N [(2 METHOXYPHENYL)METHYL]ETHANAMINE; 2 AMINOINDAN; 3,4 DICHLORO N [[1 (DIMETHYLAMINO)CYCLOHEXYL]METHYL]BENZAMIDE; 4 METHYLETHCATHINONE; 5 IODO 1 AMINOINDAN; 5 METHOXY N,N DIALLYLTRYPTAMINE; 5,6 METHYLENEDIOXY 2 INDANAMINE; 6 (2 AMINOPROPYL)BENZOFURAN; 6,7 METHYLENEDIOXY 2 AMINOTETRALIN; ALPHA METHYLTRYPTAMINE; AMITRIPTYLINE; DESIGNER DRUG; METHIOPROPAMINE; METHOXETAMINE; PSYCHOTROPIC AGENT; SERTINDOLE; UNCLASSIFIED DRUG; STREET DRUG;

ANALYTIC METHOD; ARTICLE; BLOOD ANALYSIS; DEGRADATION; DIODE ARRAY DETECTION; DRUG ABUSE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIQUID CHROMATOGRAPHY; LIQUID LIQUID EXTRACTION; MEASUREMENT ACCURACY; METABOLITE; MOLECULAR STABILITY; PRIORITY JOURNAL; QUADRUPOLE MASS SPECTROMETRY; ROOM TEMPERATURE; STORAGE; TANDEM MASS SPECTROMETRY; TIME OF FLIGHT MASS SPECTROMETRY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; BLOOD; DRUG STABILITY; METABOLISM;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG STABILITY; HUMANS; PSYCHOTROPIC DRUGS; STREET DRUGS; TANDEM MASS SPECTROMETRY;

EID: 84904559582     PISSN: 19427603     EISSN: 19427611     Source Type: Journal    
DOI: 10.1002/dta.1576     Document Type: Article

References (23)

1. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Annual report on the state of the drugs problem in Europe. Available at: http://www.emcdda.europa.eu/publications/annual-report/2012 [October 2013].
2. S.L. Hill, S.H. Thomas . Clinical toxicology of newer recreational drugs. Clin. Toxicol. 2011, 49, 705.
3. U. Boerner . Metabolism of morphine and heroin in humans (review). Drug Metab. Rev. 1975, 4, 39.
4. G. Skopp, L. Potsch, A. Klingmann, R. Mattern . Stability of morphine, morphine-3-glucuronide, and morphine-6-glucuronide in fresh blood and plasma and postmortem blood samples. J. Anal. Toxicol. 2001, 25, 2.
5. D.S. Popa, L. Vlase, S.E. Leucuta, F. Loghin . Determination of cocaine and benzoylecgonine in human plasma by LC-MS/MS. Farmacia 2009, 57, 301.
6. S.P. Elliott, K.A. Hale . A previously unidentified acepromazine metabolite in humans: Implications for the measurement of acepromazine in blood. J. Anal. Toxicol. 1999, 23, 367.
7. S. Elliott, V. Burgess . Investigative implications of the instability and metabolism of mebeverine. J. Anal. Toxicol. 2006, 30, 91.
8. J. Kristinsson, I. Snorradottir, M. Johannsson . The metabolism of mebeverine in man: Identification of urinary metabolites by gas chromatography/mass spectrometry. Pharmacol. Toxicol. 1994, 74, 174.
9. L.K. Sørensen . Determination of cathinones and related ephedrines in forensic whole-blood samples by liquid-chromatography-electrospray tandem mass spectrometry. J. Chromatogr. B 2011, 879, 727.
10. K. Tsujikawa, T. Mikuma, K. Kuwayama, H. Miyaguchi, T. Kanamori, Y.T. Iwata, H. Inoue . Degradation pathways of 4-methylmethcathinone in alkaline solution and stability of methcathinone analogs in various pH solutions. Forensic Sci. Int. 2012, 220, 103.
11. S. Elliott, C. Smith . Investigation of the first deaths in the United Kingdom involving the detection and quantitation of the piperazines BZP and 3-TFMPP. J. Anal. Toxicol. 2008, 32, 172.
12. S.P. Elliott, S.D. Brandt, S. Freeman, R.P. Archer . AMT (3-(2-aminopropyl)indole) and 5-IT (5-(2-aminopropyl)indole): An analytical challenge and implications for forensic analysis. Drug Test. Anal. 2013, 5, 196.
13. P.N. Kaul, L.R. Whitfield, M.L. Clark . Quantitative determination of amitriptyline in blood. J. Pharm. Sci. 1978, 67, 60.
14. Y. Shen, R.H. Zhu, H.D. Li, Y.W. Liu, P. Xu . Validated LC-MS (ESI) assay for the simultaneous determination of amitriptyline and its metabolite nortriptyline in rat plasma: Application to a pharmacokinetic comparison. J. Pharmaceut. Biomed. 2010, 53, 735.
15. R.D. Johnson, S.R. Botch-Jones . The stability of four designer drugs: MDPV, mephedrone, BZP and TFMPP in three biological matrices under various storage conditions. J. Anal. Toxicol. 2013, 37, 51.
16. A.J. Pedersen, L.A. Reitzel, S.S. Johansen, K. Linnet . In vitro metabolism studies on mephedrone and analysis of forensic cases. Drug Test. Anal. 2013, 5, 430.
17. M.R. Meyer, J. Wilhelm, F.T. Peters, H.H. Maurer . Beta-keto amphetamines: Studies on the metabolism of the designer drug mephedrone and toxicological detection of mephedrone, butylone, and methylone in urine using gas chromatography-mass spectrometry. Anal. Bioanal. Chem. 2010, 397, 1225.
18. E.R.H. Walker . The functional group selectivity of complex hydride reducing agents. Chem. Soc. Rev. 1976, 5, 23.
19. T. Kanamori, K. Kuwayama, K. Tsujikawa, H. Miyaguchi, Y.T. Iwata, H. Inoue . In vivo metabolism of alpha-methyltryptamine in rats: Identification of urinary metabolites. Xenobiotica 2008, 38, 1476.
20. M. Katagi, T. Kamata, K. Zaitsu, N. Shima, H. Kamata, K. Nakanishi, H. Nishioka, A. Miki, H. Tsuchihashi . Metabolism and toxicologic analysis of tryptamine-derived drugs of abuse. Ther. Drug Monit. 2010, 32, 328.
21. J.M. Corkery, S. Elliott, F. Schifano, O. Corazza, A. H. Ghodse . MDAI (5, 6-methylenedioxy-2-aminoindane 6, 7-dihydro-5H-cyclopenta[f][1, 3]benzodioxol-6-amine 'sparkle'; 'mindy') toxicity: a brief overview and update. Hum. Psychopharm. Clin. 2013, 28, 345.
22. J.L. Poklis, J. Charles, C.E. Wolf, A. Poklis . High-performance liquid chromatography tandem mass spectrometry method for the determination of 2CC-NBOMe and 25I-NBOMe in human serum. Biomed. Chromatogr. 2013, DOI: 10.1002/bmc.2999
23. D. Zuba, K. Sekula . Analytical characterization of three hallucinogenic N-(2-methoxy)benzyl derivatives of the 2C-series of phenethylamine drugs. Drug Test. Anal. 2013, 5, 634.